celiprolol has been researched along with rifampin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Lilja, JJ; Neuvonen, PJ; Niemi, M | 1 |
1 trial(s) available for celiprolol and rifampin
| Article | Year |
|---|---|
Rifampicin reduces plasma concentrations of celiprolol.
Topics: Adrenergic beta-Antagonists; Adult; Antibiotics, Antitubercular; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Celiprolol; Cross-Over Studies; Female; Genotype; Half-Life; Humans; Male; Polymorphism, Genetic; Rifampin | 2004 |
1 other study(ies) available for celiprolol and rifampin
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |